Bottom line
VGHCX vs RYHIX: the short answer
VGHCX (Vanguard Health Care Fund) and RYHIX (Health Care Fund) are both mutual funds.
VGHCX is cheaper at 0.33% vs 1.38% — a difference of $105 a year per $10,000 invested.
Over five years, VGHCX returned +6.6% a year vs +5.1% for RYHIX.
Updated Nov 19, 2026
VGHCX vs RYHIX side by side
| VGHCX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Vanguard | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.33% | 1.38% |
| Annual cost per $10k | $33 | $138 |
| 10-yr cost on $10k (prospectus) | $418 | $1,709 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +17.3% | +14.4% |
| 5-yr return (annualized) | +6.6% | +5.1% |
| 10-yr return (annualized) | +7.7% | +7.9% |
| Best quarter | +16.8% | +18.7% |
| Worst quarter | −12.3% | −14.4% |
| Net assets (fund) | $38.2B | $19.4M |
| Number of holdings | 97 | 135 |
| Portfolio turnover | 47% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VGHCX | RYHIX | Difference |
|---|---|---|---|
| 2025 | +17.3% | +14.4% | +2.9% |
| 2024 | −1.6% | +0.6% | −2.2% |
| 2023 | +5.4% | +5.8% | −0.4% |
| 2022 | −1.1% | −11.6% | +10.6% |
| 2021 | +14.3% | +19.2% | −4.9% |
| 2020 | +12.6% | +18.9% | −6.3% |
| 2019 | +22.9% | +22.8% | +0.2% |
| 2018 | +1.2% | +1.6% | −0.4% |
Source: Fund prospectus bar charts
Holdings overlap
14 of VGHCX's top 25 holdings also appear in RYHIX's top 25.
| Holding | VGHCX | RYHIX |
|---|---|---|
| Eli Lilly & Co | 8.61% | 3.63% |
| Merck & Co Inc | 5.44% | 2.04% |
| Johnson & Johnson | 4.83% | 2.88% |
| UnitedHealth Group Inc | 4.05% | 2.22% |
| Edwards Lifesciences Corp | 2.56% | 0.84% |
| Intuitive Surgical Inc | 2.52% | 1.31% |
| CVS Health Corp | 2.52% | 1.31% |
| Vertex Pharmaceuticals Inc | 2.36% | 1.34% |
| AbbVie Inc | 2.30% | 2.52% |
| Danaher Corp | 2.18% | 1.30% |
| Regeneron Pharmaceuticals Inc | 2.14% | 0.90% |
| Elevance Health Inc | 1.83% | 1.02% |
| HCA Healthcare Inc | 1.68% | 0.87% |
| Boston Scientific Corp | 1.53% | 0.86% |
Source: SEC Form N-PORT
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between VGHCX and RYHIX?
Which is cheaper, VGHCX or RYHIX?
Should I own both VGHCX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.